- Home
- MGRX
MGRX
Mangoceuticals Inc.
as 04-01-2025 4:00pm EST
| Founded: | 2021 | Country: | United States |
| Employees: | N/A | City: | DALLAS |
| Market Cap: | N/A | IPO Year: | 2023 |
| Target Price: | N/A | AVG Volume (30 days): | 261.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.84 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.80 - $16.80 | Next Earning Date: | 05-14-2025 |
| Revenue: | $615,873 | Revenue Growth: | -15.81% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Mangoceuticals Inc. News
MGRX Breaking Stock News: Dive into MGRX Ticker-Specific Updates for Smart Investing
GlobeNewswire
8 days ago
Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada
GlobeNewswire
a month ago
Mangoceuticals Announces the Launch of “PeachesRx” - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments
GlobeNewswire
2 months ago
Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution
GlobeNewswire
2 months ago
Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research
GlobeNewswire
2 months ago
Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation
GlobeNewswire
3 months ago
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent
GlobeNewswire
4 months ago
Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split
GlobeNewswire
5 months ago
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
Compare MGRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MGRX Mangoceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.